471

Compound name
Ripretinib
Alt Name
DCC-2618
Compound Image
Ripretinib.png
SMILES
CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC
MW
510.40
Brutto
C24H21BrFN5O2
InChI
InChI=1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H,27,28)(H2,29,30,33)
InChI Key
CEFJVGZHQAGLHS-UHFFFAOYSA-N
Approval Jurisdiction
2020 FDA
Approved for clinical use
Advanced GIST Mastocytosis
CAS
1442472-39-0
PubChem CID
71584930
Action
KIT; PDGFRA incl mutants
Approved Drug List
1
Commercial Vendor
Deciphera Pharmaceuticals